Skip to Content
MilliporeSigma

1.42020

SAFC

Cyclodextrin HPB

EMPROVE® EXPERT, Ph. Eur., NF

Synonym(s):

Cyclodextrin HPB, (2-Hydroxypropyl)-β-Cyclodextrin, HP-B-CD, Hydroxypropyl Betadex

Slide 1 of 1
Sign Into View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

Linear Formula:
C42H70-nO35 · (C3H7O)n
CAS Number:
MDL number:
UNSPSC Code:
12352201

Skip To


Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

agency

NF
Ph. Eur.

Quality Level

product line

EMPROVE® EXPERT

form

solid

mol wt

avg mol wt 1387.2 g/mol

pH

5.0-7.0 (20 g/L in H2O)

solubility

450 g/L

application(s)

liquid formulation
ophthalmics
pharmaceutical
solid formulation
solubility enhancement

storage temp.

15-25°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
Y0000186778966C0926
application(s)

liquid formulation
ophthalmics
pharmaceutical
solid formulation
solubility enhancement

application(s)

pharmaceutical (small molecule)

application(s)

-

application(s)

-

agency

NF, Ph. Eur.

agency

-

agency

-

agency

-

form

solid

form

-

form

powder

form

powder

solubility

450 g/L

solubility

-

solubility

-

solubility

-

product line

EMPROVE® EXPERT

product line

-

product line

-

product line

BioReagent

mol wt

avg mol wt 1387.2 g/mol

mol wt

-

mol wt

-

mol wt

1396 Da

General description

When working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and bioavailability limitations just to name a few. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our EMPROVE® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Cyclodextrin HPB (hydroxypylated β-cyclodextrin) can be used to strongly increase solubility of active pharmaceutical ingredients (APIs) by forming API:cyclodextrin inclusion complexes. It can also increase API stability and safety as well as mask undesired odors and tastes. The broad application range of Cyclodextrin HPB comprises liquid, semi-solid and solid formulations, as well as diverse routes of administration. Due to its low microbial and endotoxin limits, Cyclodextrin HPB Emprove® Expert is especially suitable for high-risk applications.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

752.0 °F

flash_point_c

> 400 °C


Stay compliant with GMP using the Emprove® Program

Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.

Download Dossiers

Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.

Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite

Not finding what you are looking for? Visit the Emprove® Program Help page.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Discover strategies to enhance solubility in injectable formulations using excipients, including cyclodextrins, meglumine, and polyethylene glycols.

This article outlines critical factors in long-term stability of proteins, and how different stabilizers protect again mechanical and thermal stress.

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

Related Content

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service